🇺🇸 FDA
Patent

US 7125541

Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy

granted A61KA61K2039/505A61K2123/00

Quick answer

US patent 7125541 (Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy) held by THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS
Grant date
Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K2123/00, A61K38/00, A61K47/6817